Some clinical stories become perennials – issues that never seem to get completely resolved and pop up year after year. What’s the betting we can see the end of any of these seven controversies in 2015?
1: Are antidepressants over-prescribed? To some, depression is under-diagnosed and under-treated. Others think we’re medicalising ordinary sadness.
2: Bariatric surgery for weight loss. A sensible approach to disease prevention, or a cop-out that means people don’t take responsibility for their own health?
3: Statins for over-50s. A worthwhile investment in preventing heart disease, or under-researched mass-medicalisation?
4: HRT for menopausal symptoms. Out of fashion since the shock research of 2003, but do too few women now benefit from their beneficial effects?
5: Should we stockpile Tamiflu against a flu pandemic? Or does the evidence now point to it being too little use, for too much cost?
6: Dementia diagnosis. Is there a good reason to increase early diagnosis of this devastating condition?
7: Tight glucose control for type 2 diabetes. The best way to avoid complications, or a short route to hypoglycemia?
I took a closer look at these questions in my January feature for Student BMJ, here.